Humphries William D.
CIK: 0001674278
Director
Primary company: Bausch Health Companies Inc. (BHC)
Humphries William D. is a corporate insider at Bausch Health Companies Inc. (BHC) filing SEC Form 4 transactions. 85 transactions across 5 companies, totaling $712,856 in purchases and $3,080,553 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 4,793 | - | - | 0 | 6/6/2025 Filed: 6/9/2025 | Filing → | |
| Exercise | 4,793 | - | - | 33,525 | 6/6/2025 Filed: 6/9/2025 | Filing → | |
| Award | 11,580 | - | - | 11,580 | 6/5/2025 Filed: 6/9/2025 | Filing → | |
| Award | 42,350 | - | - | 42,350 | 6/5/2025 Filed: 6/9/2025 | Filing → | |
Clearside Biomedical, Inc. CLSD | Award | 45,000 | - | - | 45,000 | 6/20/2024 Filed: 6/21/2024 | Filing → |
| Award | 4,793 | - | - | 4,793 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Award | 15,750 | - | - | 15,750 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Exercise | 4,660 | - | - | 0 | 6/1/2024 Filed: 6/4/2024 | Filing → | |
| Exercise | 4,660 | - | - | 28,732 | 6/1/2024 Filed: 6/4/2024 | Filing → | |
Clearside Biomedical, Inc. CLSD | Exercise | 22,727 | $0.00 | $0 | 0 | 9/22/2023 Filed: 9/22/2023 | Filing → |
Clearside Biomedical, Inc. CLSD | Exercise | 22,727 | $0.40 | $9K | 51,040 | 9/22/2023 Filed: 9/22/2023 | Filing → |
| Award | 36,408 | $1.03 | $38K | 109,724 | 7/5/2023 Filed: 7/7/2023 | Filing → | |
Clearside Biomedical, Inc. CLSD | Award | 30,000 | $0.00 | $0 | 30,000 | 6/22/2023 Filed: 6/23/2023 | Filing → |
| Exercise | 4,507 | $0.00 | $0 | 0 | 6/2/2023 Filed: 6/5/2023 | Filing → | |
| Exercise | 4,507 | - | - | 24,072 | 6/2/2023 Filed: 6/5/2023 | Filing → | |
| Award | 4,660 | $0.00 | $0 | 4,660 | 6/1/2023 Filed: 6/5/2023 | Filing → | |
| Award | 15,750 | $0.00 | $0 | 15,750 | 6/1/2023 Filed: 6/5/2023 | Filing → | |
PhaseBio Pharmaceuticals Inc PHAS | Exercise | 2,538 | $0.00 | $0 | 0 | 5/19/2023 Filed: 5/19/2023 | Filing → |
PhaseBio Pharmaceuticals Inc PHAS | Exercise | 2,538 | - | - | 2,538 | 5/19/2023 Filed: 5/19/2023 | Filing → |
Clearside Biomedical, Inc. CLSD | Award | 30,000 | $0.00 | $0 | 30,000 | 6/22/2022 Filed: 6/24/2022 | Filing → |
Type
Exercise
Shares
4,793
Price
-
Value
-
Type
Exercise
Shares
4,793
Price
-
Value
-
Type
Award
Shares
11,580
Price
-
Value
-
Type
Award
Shares
42,350
Price
-
Value
-
Clearside Biomedical, Inc.
CLSD
Type
Award
Shares
45,000
Price
-
Value
-
Type
Award
Shares
4,793
Price
-
Value
-
Type
Award
Shares
15,750
Price
-
Value
-
Type
Exercise
Shares
4,660
Price
-
Value
-
Type
Exercise
Shares
4,660
Price
-
Value
-
Clearside Biomedical, Inc.
CLSD
Type
Exercise
Shares
22,727
Price
$0.00
Value
$0
Clearside Biomedical, Inc.
CLSD
Type
Exercise
Shares
22,727
Price
$0.40
Value
$9K
Type
Award
Shares
36,408
Price
$1.03
Value
$38K
Clearside Biomedical, Inc.
CLSD
Type
Award
Shares
30,000
Price
$0.00
Value
$0
Type
Exercise
Shares
4,507
Price
$0.00
Value
$0
Type
Exercise
Shares
4,507
Price
-
Value
-
Type
Award
Shares
4,660
Price
$0.00
Value
$0
Type
Award
Shares
15,750
Price
$0.00
Value
$0
PhaseBio Pharmaceuticals Inc
PHAS
Type
Exercise
Shares
2,538
Price
$0.00
Value
$0
PhaseBio Pharmaceuticals Inc
PHAS
Type
Exercise
Shares
2,538
Price
-
Value
-
Clearside Biomedical, Inc.
CLSD
Type
Award
Shares
30,000
Price
$0.00
Value
$0
AI Agent
Try asking...